Domain Associates — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Locus Bioscienceslocus-bio.com in 𝕏Feb 2024 · $152M

Locus Biosciences develops engineered bacteriophage therapies for treating bacterial infections and conditions in immunology, oncology, and CNS disorders.

AI & Machine LearningBiotechDeep TechHealthtechRaleigh, US

Paul Garofolo(CEO & Co-founder)NICK TAYLOR(Executive Officer)PAUL GAROFOLO(Executive Officer, Director)Nick Conley(Vice President of Technology (Co-founder of EpiBiome, acquired by Locus))

BoardGEOFFREY GLASS(Director)DAVID JOHNSTON(Director)

Co-investorsArtis Ventures Abstract Ventures Hemisphere Ventures LLC Longitude Capital Starlight Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.